Recombinant Anti-BAFF x Anti-B7RP1 Bispecific Antibody (scFv-Fc) (BSCFV-018)

Recombinant Anti-BAFF x Anti-B7RP1 Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-BAFF specificity or anti-B7RP1 specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can bind and inactivate two ligands simultaneously. It can inhibit B cell survival and T cell costimulation. It is designed for the research of Systemic lupus erythematosus (SLE) therapy.

Datasheet INQUIRY

Specifications

Targets

BAFF & B7RP1

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Systemic lupus erythematosus (SLE)

Targets

Target 1

BAFF

Gene ID

10673

UniProt ID

Q9Y275

Alternative Names

TNFSF13B; TNF superfamily member 13b; DTL; B cell activating factor; BAFF; BLYS; CD257; TALL1; THANK; ZTNF4; TALL-1; TNFSF20

Target 2

B7RP1

Gene ID

23308

UniProt ID

O75144

Alternative Names

ICOSLG; inducible T cell costimulator ligand; B7H2; GL50; B7-H2; B7related protein; B7RP1; CD275; ICOSL; LICOS; B7RP-1; ICOS-L

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-BAFF x Anti-B7RP1 Bispecific Antibody (scFv-Fc) (BSCFV-018). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-BAFF x Anti-B7RP1 Bispecific Antibody (scFv-Fc) (CAT#: BSCFV-018)

Specifications

Targets

Customer Reviews and Q&As